See also this year's filing and all EDGAR filings for this company.
PDF Report 0001338042_2012_Aegerion_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001338042, Aegerion Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 74,076,612 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 526,353 |
| 3 | remainder_Assets | 965,194 |
| 4 | LiabilitiesCurrent | 9,400,388 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 8,966,430 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 39,254,113 |
| 9 | ResearchAndDevelopmentExpense | 73,557,741 |
| 10 | remainder_Expenses | 9,596,150 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,685,980 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 75,568,159 |
| 1 | Liabilities | 18,366,818 |
| 2 | Expenses | 122,408,004 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 57,201,341 |
| 5 | NetIncome | -118,722,024 |
| 6 | ComprehensiveNetIncome | -118,722,024 |
| 7 | BaseVar | 110,014,480 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.127 |
| 9 | EconomicCapitalRatio | 1.54 |
Edgar->Model Mapping
Feature Distribution
